Impact of comorbidities by ACE-27 in the revised-IPSS for patients with myelodysplastic syndromes-Reference-Cited by-同舟云学术

Impact of comorbidities by ACE-27 in the revised-IPSS for patients with myelodysplastic syndromes

Published:2014-02-21 Issue:5 Volume:89 Page:509-516
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Daver Naval¹,Naqvi Kiran²,Jabbour Elias¹,Kadia Tapan¹,DiNardo Courtney¹,Cardenas-Turanzas Marylou¹,Pierce Sherry¹,Nguyen Khanh Thi-Thuy¹,Bueso-Ramos Carlos³,Kantarjian Hagop¹,Garcia-Manero Guillermo¹

Affiliation:

1. Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston Texas

2. Department of Hematology/Oncology; Baylor College of Medicine; Houston Texas

3. Department of Hematopathology; The University of Texas MD Anderson Cancer Center; Houston Texas

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23675/fullpdf

Reference39 articles.

1. Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management;Garcia-Manero;Am J Hematol,2012

2. Myelodysplastic syndromes;Tefferi;N Engl J Med,2009

3. Proposals for the classification of the myelodysplastic syndromes;Bennett;Br J Haematol,1982

4. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes;Vardiman;Blood,2009

5. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant (chemo)radiotherapy for patients with head and neck cancer: can comorbidity risk scores predict outcome?;Strahlentherapie und Onkologie;2024-09-02

2. Individual Patient Comorbidities and Effect on Cochlear Implant Performance;Otology & Neurotology;2024-02-29

3. The impact of comorbidity on the diagnosis delay, treatment options and prognosis for advanced oral cancer: A retrospective result of the POROMS database;Journal of Cranio-Maxillofacial Surgery;2024-02

4. A retrospective validation of the IPSS-M molecular score in primary and therapy-related myelodysplastic syndromes (MDS);Leukemia & Lymphoma;2023-07-13

5. Myelodysplastic syndromes: 2023 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2023-06-08